LEP and Alzheimer disease: Furthermore, significant evidence from studies using cellular and rodent models of AD indicates that leptin-based treatments have pro-cognitive and neuroprotective actions, thereby signifying that targeting the leptin system may be advantageous in the treatment of AD (see Figure 1).